In Vitro Toxicity Evaluation of New Generic Latanost(®) and Latacom(®) as an Ophthalmic Formulation

AIM AND OBJECTIVE: To evaluate the safety of two new generic ophthalmic formulations, Latanost(®) (latanoprost) and Latacom(®) (latanoprost and timolol) by utilizing the three-dimensional reconstructed human cornea-like epithelium (RhCE) tissue constructs as an in vitro model in the assessment of oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Jessica Sze Chia, Tan, Yi Xin, Alwi, Nor Amalina Ahmad, Yee, Kar Ming, Rashid, Ahmad Hazri Abdul, Tan, Ka-Liong, Leong, Chuei Wuei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807938/
https://www.ncbi.nlm.nih.gov/pubmed/35173396
http://dx.doi.org/10.5005/jp-journals-10078-1319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807938/
https://www.ncbi.nlm.nih.gov/pubmed/35173396
http://dx.doi.org/10.5005/jp-journals-10078-1319

Ejemplares similares